Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report
Parenteral artesunate is recommended as first-line therapy for severe and complicated malaria. Although its efficacy has been proven, long-term safety profile is still under evaluation. Several cases of delaye...
Malaria Journal 2014 13:398
Published on: 11 October 2014